Follow Us
HIV Treatment and Medical Care

Approved HIV Medications

The Latest

An Overview of Lersivirine Img

An Overview of Lersivirine

**_As of February 2013, the study of lersivirine as an HIV medicine has been discontinued. See the following for more details:

As of August 11, 2014, this record is no longer being maintained._**

Other Names: U...

Promo Image

HAART, Dyslipidemia, and Hyperglycemia

HAART has been associated with the frequent appearance of dyslipidemia -- elevated total and LDL cholesterol, decreased HDL cholesterol, elevated triglycerides -- as well as hyperglycemia leading to diabetes. Dr. Morris Shambelan from San Francisco s...

Promo Image

Quantifying Abnormalities Associated with Fat Redistribution Syndrome

Many reports attempted to quantify the types of abnormalities associated with fat redistribution syndrome. Dr. Norma Muurahainen of Serono Laboratories reported on a preliminary analysis of a detailed self-assessment questionnaire performed by 208 pa...

Promo Image

Growth Hormone (rhGH) and Fat Redistribution Syndrome

Several papers concerning growth hormone (rhGH) and fat redistribution syndrome were reported. Dr. Christine Wanke from Boston reported on improvement in fat redistribution syndrome in 10 patients treated with rhGH in an ongoing 12 week study. All su...

Promo Image

Treating Fat Redistribution Syndrome

Various treatments of fat redistribution syndrome-associated lipid disorders have been reported. A study from Paris showed moderate improvement in hypertriglyceridemia with dietary intervention comparable to that recommended for non-HIV associated hy...

Promo Image

Amprenavir (Agenerase)

What Is Amprenavir?

Amprenavir is a drug used as part of antiretroviral therapy (ART). It is also called Agenerase®. It was manufactured by GlaxoSmithKline.

Manufacture of amprenavir was discontinued in October 2007. It is being replaced by fosampr...

Promo Image

Non-Nucleoside Reverse Transcriptase Inhibitors in Development

Non-Nucleoside Reverse Transcriptase Inhibitors NNRTIs in Development NNRTIs No Longer in Development

Note: Several fact sheets describe drugs that are being tested against HIV:

Fact Sheet 410: nucleoside analog reverse transcriptase inhibito...

Promo Image

Protease Inhibitors in Development

Protease Inhibitors Protease Inhibitors in Development PIs No Longer in Development

NOTE: Several fact sheets describe drugs that are being tested against HIV:

Fact Sheet 410: nucleoside analog reverse transcriptase inhibitors (nukes) Fact ...

Promo Image

Agenerase (Amprenavir, APV)

  Brand Name: AgeneraseCommon Name: amprenavirClass: HIV protease inhibitor (PI)Standard Dose: 1200 mg twice daily. The 150 mg soft gelatin capsules were taken off the market because of the new formulation (Lexiva), but the 50 mg capsule an...

Promo Image

New Drugs From Old Classes

A number of new drugs from existing classes are being studied. Here's a brief rundown of drugs that have started trials in people:

Nucleoside Analog Reverse Transcriptase Inhibitors (NRTIs)

Amdoxovir (DAPD): Early results from an ongoing Phase II s...